CP
DEAD

Serial Number

88086677

Owner

Clinipace, Inc.

Attorney

Theresa D. Koller

First Use Date

Jun 22, 2018

Filing Date

Aug 21, 2018

Add to watchlist:

No watchlists yet
View on USPTO

CP Trademark

Serial Number: 88086677 • Registration: 5818057

CP is a trademark filed by Clinipace, Inc. on August 21, 2018. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Clinipace, Inc. (14 trademarks)

Suite 100
Morrisville, NC 27560

Entity Type: 03

Trademark Details

Filing Date

August 21, 2018

Registration Date

July 30, 2019

First Use Anywhere

June 22, 2018

First Use in Commerce

June 22, 2018

Published for Opposition

May 14, 2019

Cancellation Date

February 13, 2026

Goods & Services

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; providing independent review of clinical trials for business purposes; Contract research organization (CRO) services, namely, business management in the field of clinical trials, namely, clinical data management

Contract research organization (CRO) services, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes, and clinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areas, in particular gastroenterology, nephrology, urology, and oncology; consulting services in the field of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, biologics and medical devices

Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields

Contract research organization (CRO) services, namely, custom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 13, 2026 C8..
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 30, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 30, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 30, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 30, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 30, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 30, 2025 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 30, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 30, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 14, 2019 NPUB
PUBLISHED FOR OPPOSITION
May 14, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2019 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 5, 2019 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 5, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 5, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 5, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 5, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 3, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 3, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 3, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 14, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jan 14, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jan 14, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2018 CRFA
ASSIGNED TO LIE
Dec 21, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 18, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 8, 2018 GNRN
NON-FINAL ACTION E-MAILED
Dec 8, 2018 GNRT
NON-FINAL ACTION WRITTEN
Dec 8, 2018 CNRT
ASSIGNED TO EXAMINER
Dec 6, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 29, 2018 NWOS
NEW APPLICATION ENTERED
Aug 24, 2018 NWAP